Serotonin-norepinephrine reuptake inhibitor desvenlafaxine for the treatment of interferon alfa-associated depression in patients with hepatitis C.
Infectious Diseases Reference Center-CTR-DIP Orestes Diniz, Universidade Federal de Minas Gerais (UFMG), Belo Horizonte, MG, Brazil.
Bruno
B
Fábregas
Infectious Diseases Reference Center-CTR-DIP Orestes Diniz, Universidade Federal de Minas Gerais (UFMG), Belo Horizonte, MG, Brazil.
Alexandre
A
Moura
Infectious Diseases Reference Center-CTR-DIP Orestes Diniz, Universidade Federal de Minas Gerais (UFMG), Belo Horizonte, MG, Brazil.
Renata
R
Ávila
Infectious Diseases Reference Center-CTR-DIP Orestes Diniz, Universidade Federal de Minas Gerais (UFMG), Belo Horizonte, MG, Brazil.
Ricardo
R
Carmo
Tropical Medicine Program, School of Medicine, UFMG, Belo Horizonte, MG, Brazil.
Antônio Lúcio
AL
Teixeira
D000998:Antiviral Agents / Q000009:adverse effects*; D003511:Cyclohexanols / Q000627:therapeutic use*; D003866:Depressive Disorder / Q000139:chemically induced / Q000188:drug therapy*; D000069468:Desvenlafaxine Succinate; D019698:Hepatitis C, Chronic / Q000188:drug therapy*; D006801:Humans; D016898:Interferon-alpha / Q000009:adverse effects*; D008297:Male; D008875:Middle Aged; D017367:Selective Serotonin Reuptake Inhibitors / Q000627:therapeutic use*; D013997:Time Factors; D016896:Treatment Outcome
D000998:Antiviral Agents; D003511:Cyclohexanols; D000069468:Desvenlafaxine Succinate; D016898:Interferon-alpha; D017367:Selective Serotonin Reuptake Inhibitors